Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2018 08:00 ET | Source: EndoLogic

EndoLogic Announces FDA Accepts Cardiac Safety Trial for Renzapride in Patients with Gastroparesis

Study demonstrates no evidence of QTc prolongation EndoLogic remains on plan to initiate 12-week renzapride Phase 2 trial pending collaboration with a development partner CLIFTON, N.J., May 15,...
August 09, 2017 08:00 ET | Source: EndoLogic

EndoLogic Announces Feedback from Positive FDA Meeting for Renzapride in Diabetic Gastroparesis

FDA pre-IND meeting minutes describe steps required for new drug application (NDA) submission No additional toxicology studies required to initiate Phase 2 trial EndoLogic will move forward with a...
May 03, 2017 08:30 ET | Source: EndoLogic

EndoLogic Announces Scheduling of pre-IND Meeting with FDA to Discuss Renzapride in Diabetic Gastroparesis

CLIFTON, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- EndoLogic, a company focused on the development and commercialization of products that treat gastrointestinal diseases, announced that the FDA has...
January 03, 2017 08:00 ET | Source: EndoLogic

EndoLogic Acquires Renzapride from Alizyme, plc

CLIFTON, N.J., Jan. 03, 2017 (GLOBE NEWSWIRE) -- EndoLogic, a company focused on the development and commercialization of products that treat gastrointestinal diseases, has acquired the worldwide...